Literature DB >> 33053053

Toxoplasma gondii and Neospora caninum infections and factors associated in goats in the Parana state, Southern Brazil.

Paulo Roberto Romanelli1, Andressa Maria Rorato Nascimento de Matos1, Fernanda Pinto-Ferreira1, Eloiza Teles Caldart1, Juliana Silva de Oliveira1, Gabriela Anteveli1, Brenda Caroline Dos Santos Jeanfelice1, Rafael Luiz Stolf1, Tainá Favoreto Sanches1, Mariana Kassab E Silva1, Alessandro Pelegrine Minho2, Antônio Cezar Rocha Cavalcante2, Roberta Lemos Freire1, Regina Mitsuka-Breganó1, Italmar Teodorico Navarro1.   

Abstract

The aim of this study was to determine the occurrence of anti-Toxoplasma gondii and anti-Neospora caninum antibodies and their associated factors among goats in farms from the Paraná state, South Brazil. The serological analysis was performed by indirect ELISA on 629 goat serum samples collected from 32 farms distributed in five mesorregions from the state. Seropositivity was observed in 30.7% of the animals for T. gondii, 6.3% for N. caninum, and 3.0% for both agents. Final multiple regression models showed that the use of assisted reproduction decreased the chance of seropositivity for T. gondii (PR=0.70) and the slaughtering site on the farm (PR=2.03) increased it. To N. caninum, the supplying concentrated feed to animals (OR=4.80) and animal pre-weaning death (OR=9.96) increased the chance of seropositivity. The variables associated with these seropositivities suggest deficiencies in sanitation and reproductive management. In addition, it recognizes critical points of infection for animal production management.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33053053     DOI: 10.1590/S1984-29612020076

Source DB:  PubMed          Journal:  Rev Bras Parasitol Vet        ISSN: 0103-846X


  1 in total

1.  Apicomplexans in Goat: Prevalence of Neospora caninum, Toxoplasma gondii, Cryptosporidium spp., Eimeria spp. and Risk Factors in Farms from Ecuador.

Authors:  Kevin Celi; Lucía Guzmán; Catalina Rey-Valeirón
Journal:  Animals (Basel)       Date:  2022-08-29       Impact factor: 3.231

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.